FDA Inspection 1286174 — Rebecca Hartman, M.D., M.P.H.
The FDA completed an inspection of Rebecca Hartman, M.D., M.P.H. on Oct 1, 2025 in Jamaica Plain, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 1, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Jamaica Plain, MA (United States)
Additional details
Clinical Investigator (CI)